AGL 38.89 Increased By ▲ 0.87 (2.29%)
AIRLINK 206.65 Increased By ▲ 9.29 (4.71%)
BOP 9.52 Decreased By ▼ -0.02 (-0.21%)
CNERGY 6.03 Increased By ▲ 0.12 (2.03%)
DCL 8.95 Increased By ▲ 0.13 (1.47%)
DFML 37.70 Increased By ▲ 1.96 (5.48%)
DGKC 97.50 Increased By ▲ 0.64 (0.66%)
FCCL 35.30 Increased By ▲ 0.05 (0.14%)
FFBL 88.94 Increased By ▲ 6.64 (8.07%)
FFL 13.55 Increased By ▲ 0.38 (2.89%)
HUBC 128.25 Increased By ▲ 0.70 (0.55%)
HUMNL 13.51 Increased By ▲ 0.01 (0.07%)
KEL 5.40 Increased By ▲ 0.08 (1.5%)
KOSM 7.13 Increased By ▲ 0.13 (1.86%)
MLCF 44.50 Decreased By ▼ -0.20 (-0.45%)
NBP 60.45 Decreased By ▼ -0.97 (-1.58%)
OGDC 215.91 Increased By ▲ 1.24 (0.58%)
PAEL 40.92 Increased By ▲ 2.13 (5.49%)
PIBTL 8.40 Increased By ▲ 0.15 (1.82%)
PPL 195.70 Increased By ▲ 2.62 (1.36%)
PRL 39.29 Increased By ▲ 0.63 (1.63%)
PTC 26.69 Increased By ▲ 0.89 (3.45%)
SEARL 107.00 Increased By ▲ 3.40 (3.28%)
TELE 8.63 Increased By ▲ 0.33 (3.98%)
TOMCL 36.15 Increased By ▲ 1.15 (3.29%)
TPLP 13.80 Increased By ▲ 0.50 (3.76%)
TREET 24.38 Increased By ▲ 2.22 (10.02%)
TRG 61.15 Increased By ▲ 5.56 (10%)
UNITY 32.77 Decreased By ▼ -0.20 (-0.61%)
WTL 1.68 Increased By ▲ 0.08 (5%)
BR100 11,930 Increased By 203.1 (1.73%)
BR30 36,808 Increased By 431.2 (1.19%)
KSE100 112,022 Increased By 2508.5 (2.29%)
KSE30 35,322 Increased By 808.2 (2.34%)
Business & Finance

Germany expects 40.2mn doses of Biontech COVID vaccine in Q2

  • The document, which was prepared for a virtual meeting of Chancellor Angela Merkel with the 16 state premiers and representatives of pharmaceutical companies and the European Union later on Monday.
Published February 1, 2021

BERLIN: The German government expects 40.2 million doses of Biontech/Pfizer's COVID-19 vaccine in the second quarter, a government document seen by Reuters on Monday showed.

The document, which was prepared for a virtual meeting of Chancellor Angela Merkel with the 16 state premiers and representatives of pharmaceutical companies and the European Union later on Monday, also said that the government sees potential delivery and production risks.

Comments

Comments are closed.